also known experimental cognitive enhancing drug nootropic currently undergoing clinical trials currently licensed helicon therapeutics san diego california originally discovered tested part preclinical antiinflammatory program inflazyme appears act inhibitor thereby increasing camp levels camp levels increased neurons may trigger activation camp response elementbinding proteins creb crebs transcription factors involved formation longterm side effects drug yet fully known study found significantly boosted memory formation mice data also indicated may effective treat ageassociated memory impairment